Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
09/07/202006:30PR Newswire (US)Regeneron to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call and Webcast on August 5, 202...NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/07/202006:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/07/202006:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/07/202002:30Dow Jones NewsU.S. Commits $2 Billion for Covid-19 Vaccine, Drug Supplies -- UpdateNASDAQ:REGNRegeneron Pharmaceuticals Inc
08/07/202000:59Dow Jones NewsU.S. Commits $2 Billion for Covid-19 Vaccine, Drug SuppliesNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/07/202021:44Dow Jones NewsRegeneron Gets Federal Manufacturing Contract for Covid-19 CocktailNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/07/202021:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/07/202021:00PR Newswire (US)Regeneron Announces Manufacturing and Supply Agreement for BARDA and U.S. Department of Defense for REGN-COV2 Anti-Viral Anti...NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/07/202002:40Dow Jones NewsRegeneron Advances Covid-19 Drug Into Later-Stage TestingNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/07/202021:48Dow Jones NewsRegeneron Embarks on Phase 3 Covid-19 Prevention TrialNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/07/202021:00PR Newswire (US)Regeneron Announces Start of REGN-COV2 Phase 3 COVID-19 Prevention Trial in Collaboration with National Institute of Allergy ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
03/07/202008:17Dow Jones NewsArthritis Drug Fails in Study of Covid-19 PatientsNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/07/202007:22Dow Jones NewsRegeneron, Sanofi Say Kevzara Phase 3 U.S. Trial in Covid-19 Patients Didn't Meet EndpointsNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/07/202006:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
03/07/202006:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
03/07/202006:29PR Newswire (US)Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 PatientsNASDAQ:REGNRegeneron Pharmaceuticals Inc
01/07/202006:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
30/06/202006:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
29/06/202022:15Dow Jones NewsKiniksa: Phase 3 Rilonacept Study Meets Key Endpoints in Recurrent PericarditisNASDAQ:REGNRegeneron Pharmaceuticals Inc
27/06/202004:43Dow Jones NewsCorrection to Coronavirus Treatment ArticleNASDAQ:REGNRegeneron Pharmaceuticals Inc
26/06/202023:32Dow Jones NewsThe Butcher's Son Seeking a Drug That Can Cut Down CoronavirusNASDAQ:REGNRegeneron Pharmaceuticals Inc
25/06/202006:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
25/06/202005:22PR Newswire (US)Regeneron to Vigorously Defend Allegations Related to Contributions to a Patient Assistance Charity in 2013 and Early 2014NASDAQ:REGNRegeneron Pharmaceuticals Inc
25/06/202004:00PR Newswire (US)New Publication Highlights Preclinical Research Showing Potential to Enhance Cancer Treatment by Combining Novel Costimulator...NASDAQ:REGNRegeneron Pharmaceuticals Inc
23/06/202006:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
22/06/202021:00PR Newswire (US)Regeneron Announces the 2020 Winners of the Regeneron Prize for Creative InnovationNASDAQ:REGNRegeneron Pharmaceuticals Inc
20/06/202003:51PR Newswire (US)FDA approves new Dupixent® (dupilumab) pre-filled pen designed to support more convenient self-administrationNASDAQ:REGNRegeneron Pharmaceuticals Inc
20/06/202003:44PR Newswire (US)FDA Approves New Dupixent® (dupilumab) Pre-filled Pen Designed to Support More Convenient Self-AdministrationNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/06/202021:30PR Newswire (US)Dupixent® (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
18/06/202007:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN